“…In the late stages of apoptosis, nuclei fragment and condense to form distinct apoptotic bodies (Gregory and Devitt, 2004). It is possible that the reported increase in the immunogenicity of poly I:C-electroporated leuke mic cells (Lion et al, 2009(Lion et al, , 2011(Lion et al, , 2014Smits et al, 2007) is not solely due to recognition of apoptotic tu mour cells, but could potentially be a response to ne crotic tumour cells. The decision of antigenpresenting cells, such as DCs, to mount an immunogenic or tolero genic adaptive immune response against internalized material has strong implications in devising the most ap propriate immunotherapeutic treatment for leukemic diseases such as AML.…”